Jarratt Pytell, MD

Assistant Professor, Medicine-Internal Medicine

FacultyPhoto
Medical School
  • MD, Louisiana State University School of Medicine in New Orleans (2015)
Graduate School
  • MHS, Johns Hopkins University Bloomberg School of Public Health (2020)
Undergraduate School
  • BA, University of Colorado - Boulder (CO) (2008)
Residency
  • Johns Hopkins University/Bayview Medical Center Program, Internal Medicine (2018)
Fellowships
  • Johns Hopkins University School of Medicine Program, Addiction Medicine (2019)
Department
Medicine-Internal Medicine

Professional Titles

  • Clinician-Investigator

Research Interests

My research is focused on how to improve the care of people who use alcohol and other drugs in primary care and other general medical settings. This includes conducting research on evidence-based drug testing, understanding the impact of alcohol and other drug use among people with HIV, and a recent focus on implementing patient-reported outcome measures in office-based addiction treatment.

Publications

  • Campopiano von Klimo M, Nolan L, Corbin M, Farinelli L, Pytell JD, Simon C, Weiss ST, Compton WM. Physician Reluctance to Intervene in Addiction: A Systematic Review. JAMA Netw Open. 2024 Jul 1;7(7):e2420837. PubMed PMID: 39018077
  • Pytell JD, Narwaney KJ, Nguyen AP, Glanz JM, Binswanger IA. New Alcohol-related Condition Diagnoses Are Associated With Opioid Tapers Among Patients Receiving Long-term Opioid Therapy. J Addict Med. 2024 Nov 26. [Epub ahead of print] PubMed PMID: 39591621
  • Hwang YJ, Lesko CR, Brown TT, Alexander GC, Zalla LC, Keruly JC, Snow LN, Pytell JD, Falade-Nwulia O, Jones JL, Moore RD, Fojo AT. Association between switching to integrase strand transfer inhibitors and incident diabetes in people with HIV. AIDS. 2024 Sep 1;38(11):1696-1702. PubMed PMID: 38864578
  • Pytell JD, Binswanger IA. Addressing Opioid Use Disorder in Primary Care: Revisiting Core Primary Care Principles to Confidently Initiate Treatment. J Gen Intern Med. 2024 Jul;39(9):1749-1750. PubMed PMID: 38519747
  • Verinumbe T, Lesko CR, Moore RD, Fojo AT, Keruly J, Snow LN, Hutton H, Chander G, Pytell JD, Falade-Nwulia O. The association of changes in depression severity after the onset of the COVID-19 pandemic and viral nonsuppression among people with HIV. AIDS. 2024 May 1;38(6):887-894. PubMed PMID: 38170505
  • Pytell JD, Fojo AT, Keruly JC, Snow LN, Falade-Nwulia O, Moore RD, Chander G, Lesko CR. Measuring time in buprenorphine treatment stages among people with HIV and opioid use disorder by retention definition and its association with cocaine and hazardous alcohol use. Addict Sci Clin Pract. 2023 Sep 2;18(1):51. PubMed PMID: 37660116
  • Lesko CR, Falade-Nwulia OO, Pytell JD, Hutton HE, Fojo AT, Keruly JC, Moore RD, Chander G. Joint effects of substance use disorders and recent substance use on HIV viral non-suppression among people engaged in HIV care in an urban clinic, 2014-2019. Addiction. 2023 Nov;118(11):2193-2202. PubMed PMID: 37491566
  • Pytell JD, Li X, Thompson C, Lesko CR, McCaul ME, Hutton H, Scott Batey D, Cachay E, Mayer KH, Napravnik S, Christopoulos K, Yang C, Crane HM, Chander G, Lau B. The temporal relationship of alcohol use and subsequent self-reported health status among people with HIV. Am J Med Open. 2023 Jun;9. PubMed PMID: 37476695
  • Thakrar AP, Pytell JD, Stoller KB, Walters V, Weiss RD, Chander G. Transitioning off methadone: A qualitative study exploring why patients discontinue methadone treatment for opioid use disorder. J Subst Use Addict Treat. 2023 Jul;150:209055. PubMed PMID: 37088398
  • Pytell JD, Whitley P, Passik SD, Bundy WL, Dawson E, Saloner B. Association of Patients' Direct Addition of Buprenorphine to Urine Drug Test Specimens With Clinical Factors in Opioid Use Disorder. JAMA Psychiatry. 2023 May 1;80(5):459-467. PubMed PMID: 36947029
  • Pytell JD, Rubenstein LV. So What Do We Do Now? New Opioid Prescribing Guidelines, Implementation Science, and How to Improve the Care of Patients Receiving Long-Term Opioid Therapy in Primary Care. J Gen Intern Med. 2023 Jun;38(8):1791-1793. PubMed PMID: 36922469
  • Pytell JD, Rubenstein LV. So What Do We Do Now? New Opioid Prescribing Guidelines, Implementation Science, and How to Improve the Care of Patients Receiving Long-Term Opioid Therapy in Primary Care. J Gen Intern Med. 2023 Mar 10. [Epub ahead of print] PubMed PMID: 36897541
  • Pytell JD, Chander G, Thakrar AP, Ogunwole SM, McGinty EE. Does a Survivorship Model of Opioid Use Disorder Improve Public Stigma or Policy Support? A General Population Randomized Experiment. J Gen Intern Med. 2023 May;38(7):1638-1646. PubMed PMID: 36394698
  • Kroll-Desrosiers A, Gutierrez J, Pytell JD. From the Editor's Desk: Ethics in Reviewing. J Gen Intern Med. 2023 Jan;38(1):1-2. PubMed PMID: 36223041
  • Pytell JD, Sklar MD, Carrese J, Rastegar DA, Gunn C, Chander G. "I'm a Survivor": Perceptions of Chronic Disease and Survivorship Among Individuals in Long-Term Remission from Opioid Use Disorder. J Gen Intern Med. 2022 Feb;37(3):593-600. PubMed PMID: 34027611
  • Levander XA, Pytell JD, Stoller KB, Korthuis PT, Chander G. COVID-19-related policy changes for methadone take-home dosing: A multistate survey of opioid treatment program leadership. Subst Abus. 2022;43(1):633-639. PubMed PMID: 34666636
  • Pytell JD, Thakrar AP, Chander G, Colantuoni E. Changes in Alcohol Consumption by Beverage Type Attributable to the COVID-19 Pandemic for 10 States, March 2020 to November 2020: An Ecological Simulation-based Analysis. J Addict Med. 2022 Jun 25. [Epub ahead of print] PubMed PMID: 35749776
  • Pytell JD, Shen NM, Keruly JC, Lesko CR, Lau B, Fojo AT, Baum MK, Gorbach PM, Javanbakht M, Kipke M, Kirk GD, Mustanski B, Shoptaw S, Siminski S, Moore RD, Chander G. The relationship of alcohol and other drug use during the COVID-19 pandemic among people with or at risk of HIV; A cross-sectional survey of people enrolled in Collaborating Consortium of Cohorts Producing NIDA Opportunities (C3PNO) cohorts. Drug Alcohol Depend. 2022 Mar 3;:109382. [Epub ahead of print] PubMed PMID: 35331580
  • Lesko CR, Keruly JC, Moore RD, Shen NM, Pytell JD, Lau B, Fojo AT, Mehta SH, Kipke M, Baum MK, Shoptaw S, Gorbach PM, Mustanski B, Javanbakht M, Siminski S, Chander G. COVID-19 and the HIV continuum in people living with HIV enrolled in Collaborating Consortium of Cohorts Producing NIDA Opportunities (C3PNO) cohorts. Drug Alcohol Depend. 2022 Feb 12;:109355. [Epub ahead of print] PubMed PMID: 35331581
  • Pytell JD, Li X, Thompson C, Lesko CR, Hutton H, McCaul ME, Hutton H, Batey DS, Cachay E, Mayer KH, Napravnik S, Christopoulos K, Yang C, Crane HM, Chander G, & Lau B. The temporal relationship of alcohol use and subsequent self-reported health status among people with HIV. American Journal of Medicine Open. Published online June 2022:100020. DOI: doi:10.1016/j.ajmo.2022.100020
  • Lesko CR, Keruly JC, Moore RD, Shen NM, Pytell JD, Lau B, Fojo AT, Mehta SH, Kipke M, Baum MK, Shoptaw S, Gorbach PM, Mustanski B, Javanbakht M, Siminski S, Chander G. COVID-19 and the HIV continuum in people living with HIV enrolled in Collaborating Consortium of Cohorts Producing NIDA Opportunities (C3PNO) cohorts. Drug Alcohol Depend. 2022 Dec 1;241:109355. PubMed PMID: 35331581
  • Pytell JD, Shen NM, Keruly JC, Lesko CR, Lau B, Fojo AT, Baum MK, Gorbach PM, Javanbakht M, Kipke M, Kirk GD, Mustanski B, Shoptaw S, Siminski S, Moore RD, Chander G. The relationship of alcohol and other drug use during the COVID-19 pandemic among people with or at risk of HIV; A cross-sectional survey of people enrolled in Collaborating Consortium of Cohorts Producing NIDA Opportunities (C3PNO) cohorts. Drug Alcohol Depend. 2022 Dec 1;241:109382. PubMed PMID: 35331580
  • Pytell JD, Chander G, Thakrar AP, Ogunwole SM, McGinty EE. Does a Survivorship Model of Opioid Use Disorder Improve Public Stigma or Policy Support? A General Population Randomized Experiment. J Gen Intern Med. 2022 Nov 17. [Epub ahead of print] PubMed PMID: 36394698
  • Pytell JD, Thakrar AP, Chander G, Colantuoni E. Changes in Alcohol Consumption by Beverage Type Attributable to the COVID-19 Pandemic for 10 States, March 2020 to November 2020: An Ecological Simulation-based Analysis. J Addict Med. 2022 Nov-Dec 01;16(6):e412-e416. PubMed PMID: 35749776
  • Kroll-Desrosiers A, Gutierrez J, Pytell JD. From the Editor's Desk: Ethics in Reviewing. J Gen Intern Med. 2022 Oct 12. [Epub ahead of print] PubMed PMID: 36223041
  • Pytell JD, Sklar MD, Carrese J, Rastegar DA, Gunn C, Chander G. "I'm a Survivor": Perceptions of Chronic Disease and Survivorship Among Individuals in Long-Term Remission from Opioid Use Disorder. J Gen Intern Med. 2022 Feb;37(3):593-600. PubMed PMID: 34027611
  • Levander XA, Pytell JD, Stoller KB, Korthuis PT, Chander G. COVID-19-related policy changes for methadone take-home dosing: A multistate survey of opioid treatment program leadership. Subst Abus. 2022;43(1):633-639. PubMed PMID: 34666636
  • Pytell JD, Li X, Thompson C, Lesko CR, Hutton H, McCaul ME, Hutton H, Batey DS, Cachay E, Mayer KH, Napravnik S, Christopoulos K, Yang C, Crane HM, Chander G, & Lau B. The temporal relationship of alcohol use and subsequent self-reported health status among people with HIV. American Journal of Medicine Open. Published online June 2022:100020. DOI: doi:10.1016/j.ajmo.2022.100020
  • Pytell JD, Rastegar DA. Down the drain: Reconsidering routine urine drug testing during the COVID-19 pandemic. J Subst Abuse Treat. 2021 Jan;120:108155. PubMed PMID: 33298297
  • Pytell JD, Sharfstein JM, Olsen Y. Facilitating Methadone Use in Hospitals and Skilled Nursing Facilities. JAMA Intern Med. 2020 Jan 1;180(1):7-8. PubMed PMID: 31738376
  • Pytell JD, Sharfstein JM, Olsen Y. Additional Barriers to Methadone Use in Hospitals and Skilled Nursing Facilities-Reply. JAMA Intern Med. 2020 Apr 1;180(4):615. PubMed PMID: 32250404
  • Callan J, Pytell J, Ross J, Rastegar DA. Transition From Methadone to Buprenorphine Using a Short-acting Agonist Bridge in the Inpatient Setting: A Case Study. J Addict Med. 2020 Sep Oct;14(5):e274-e276. PubMed PMID: 31977358
  • Pytell JD & Rastegar DA. Cannabinoids. In: Rastegar DA & Fingerhood M, eds. The American Society of Addiction Medicine Handbook of Addiction Medicine. Second Edition. Oxford, UK: Oxford University Press.
  • Olsen Y, Alvanzo A, & Pytell JD. Barriers and Advantages of Utilization of FDA-Approved Medications for Substance Use Disorders. In: Moeller FG & Terplan M, eds. A Primer on Substance Use Disorders. First Edition. Oxford, UK, Oxford University Press
  • Pytell JD, Buresh ME, Graddy R. Outcomes of a novel office-based opioid treatment program in an internal medicine resident continuity practice. Addict Sci Clin Pract. 2019 Dec 19;14(1):46. PubMed PMID: 31856915
  • Pytell JD, Rastegar DA. Who Leaves Early? Factors Associated With Against Medical Advice Discharge During Alcohol Withdrawal Treatment. J Addict Med. 2018 Nov Dec;12(6):447-452. PubMed PMID: 29939873

Professional Memberships

  • American Society of Addiction Medicine, Member
  • Society of General Internal Medicine, Member

Practice Locations

Denver Health
777 Bannock St
Denver, CO 80204
303-436-6000

Hospital Affiliation
  • Denver Health Medical Center

Clinical Interests
I am a general internist and addiction medicine specialist. I specialize in caring for people who use alcohol and other drugs to address substance use and co-occurring medical conditions.

Care Philosophy
Medicine is a public trust. I therefore strive to provide evidence-based, patient-centered care to all patients with a focus on caring for people who use alcohol and other drugs.


School of Medicine

CU Anschutz
Fitzsimons Building

13001 East 17th Place

Aurora, CO 80045

303.724.5375

School
General
Students